Clinical Trial Update: PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA. [Phase 3]

View source ↗

Summary

A Phase III randomized, active-controlled trial evaluating the efficacy and safety of nifedipine extended-release 30 mg in adults with mild to moderate hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hypertension

Drugs mentioned

• Nifedipine ER 30 mg (Nifedipine)

Snippet

Sponsor: Laboratorios Richmond S.A.C.I.F. | Conditions: High Blood Pressure (& [Essential Hypertension]) | Phase 3 | Status: COMPLETED